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Abstract 
Purpose: To optimize a geometrical design of three-layered tablets for controlling the release of 
indomethacin (Ind) as a BCS class II model. 
Methods: The core formulation was optimized to ensure non-disintegrating tablet with a slow release 
behavior. Three-layered tablets were prepared by a single-step direct compression method by manual 
feeding of a hydrophobic layer in the bottom followed by Ind core layer and another hydrophobic layer at 
the top using 6 and 12 mm round compression sets. Four batches were prepared, differing only in either 
thickness of the drug layer or tablet diameter. A number of factors were studied, including tablet 
thickness to diameter ratio and drug layer surface area. The rate of Ind released was determined using 
USP dissolution apparatus I. 
Results: The optimum drug layer formulation contained Ind (40%), polyvinylpyrolidone K30 (40 %), and 
ethyl cellulose (20 %). The t50% (time taken for 50 % drug release) for the four three-layered tablet 
batches with varying diameter to thickness ratios were in the range of 1.5 to 3.7 h. The diameter to 
thickness ratios were in good correlation with % Ind release after 4 h (R2 = 0.94). It was found that all 
batches complied with zero order kinetic model. 
Conclusion: The new one-compression phase applied in this study is successful in producing three-
layered tablets in a single-step with very good mechanical attributes. The approach of designing a 
controlled release tablet via control of the surface area of drug release is feasible for non-swelling 
matrices. 
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The ultimate goal of oral controlled drug delivery 
systems is to maintain therapeutic drug blood 
levels almost constant for a certain period of time 
after per-oral administration [1,2]. Minimizing 
adverse effects associated with high plasma drug 
concentration, reducing the frequency of dosing, 
and higher patient compliance are considered 
the major advantages of oral controlled release 
systems [1]. Despite the huge number of 
marketed oral controlled release products, only 
three approaches are employed including matrix, 
reservoir, osmotic, or ion exchange [3]. Multi-
layered tablets and technologies such as 
Geomatrix® and Smartrix® are considered typical 
examples of correlating the system dimensions 
with the release behavior [4-6].  These systems 
were able to achieve kinetic models close to 
zero-order release kinetics from hydrophilic 
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matrix tablets [7,8]. The key factor in the design 
of such systems is to maintain a constant surface 
area available for drug release [9,10]. 
 
Multi-layered tablets have showed a growing 
attention as a useful controlled release tool with 
multiple other applications such as drug 
combinations with reduced chance of interaction 
and/or inducing multi-drug release profiles in one 
dosage form [11].  
 
Sandwich-like three-layered tablets with drug 
core middle layer and two barrier layers is more 
reliable for constant rate release purpose. The 
main factors that affect the performance of such 
system are the nature and ratio of both the 
barrier and core layers and the geometrical 
design of the tablet [12]. Hydrophilic polymers 
such as hydroxyl propyl cellulose (HPC) and 
polyethylene oxide (PEO) and the hydrophobic 
polymer such as cellulose acetate propionate 
(CAP) and ethyl cellulose (EC) are possible 
candidates for the barrier layer. The 
incorporation of a release retarding polymer in 
the core layer can also be employed in certain 
designs. Geometric factors such as the core 
thickness or ratio of core thickness to diameter 
are the main design related parameters that are 
usually manipulated for optimization [13]. 
 
This study aims to optimize a three-layered tablet 
as geometrically controlled release system for 
Ind, a model drug for Biopharmaceutical 






Indomethacin, Avicel PH101, starch 1500, 
magnesium stearate, HPMC K100, K1500, 
K4000, ethylcellulose, polyvinylpyrolidone, and 
talc were purchased from Sigma-Aldrich 
Chemical Co. (St Louis, MO, USA). All other 
reagents and chemicals were of analytical grade.  
 
Preparation of the core tablet 
 
The core tablet formula was first optimized to 
give a good integrity, mechanical, and Ind 
release controlling properties. Direct 
compression method was employed and various 
compositions were attempted. Various 
combinations of excipients in varying ratios were 
tried including, anhydrous lactose, Avicel Ph101, 
polyvinylpyrolidone (PVP), HPMC and 
ethylecellulose. A formula containing Ind (40 %), 
ethylecellulose (20 %), magnesium steararte (1 
%), and PVP (39 %) showed optimum properties 
and were employed for the preparation of the 
three-layered tablets.  
 
Preparation of three-layered tablets 
 
Three-layered tablets were prepared by a single-
step direct compression method by manual 
feeding of a hydrophobic barrier layer in the 
bottom followed by Ind core layer and another 
hydrophobic barrier layer at the top. Two round 
compression sets; 6mm and 12 mm were used. 
Both the upper and bottom layers were 
composed of EC containing 1 % of magnesium 
stearate. Four batches were prepared differing 
only in either thickness of the drug layer or the 
tablet diameter. Table 1 shows the exact 
composition of each batch. Number of factors 
was studied including, tablet thickness to 
diameter ratio and the drug layer surface area. 
 
Evaluation of prepared three-layered tablets 
 
All the prepared three-layered tablets formulae 
were evaluated for the uniformity of the tablets 
and barrier layers thickness and the in vitro 
release characteristics. 
 
Uniformity of thickness  
 
The thickness of 10 three-layered tablets were 
individually measured using a micrometer, and 
the thickness of each barrier layer in each of the 
10 tablets was also determined. 
 
In vitro release 
 
The drug release profile from each of the 
prepared three-layered tablet formula will be 
monitored by placing a sample of three tablets in 
USP dissolution apparatus II (Paddle method) in 
phosphate buffer pH 7.2 at 37 °C ± 0.5 applying 
a rotating speed of 50 rpm. 
 
Table 1: Composition of the prepared tablet formulations 
 
Variable              Batch 1 Batch 2 Batch 3 Batch 4 
Ind 10mg 20mg 40mg 80mg 
EC 5mg 10mg 20mg 40mg 
PVP 10mg 20mg 40mg 80mg 
Top layer (EC) 50mg 50mg 200mg 200mg 
Bottom layer (EC) 50mg 50mg 200mg 200mg 
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Samples of 5 mL were withdrawn manually at 
certain time intervals and replaced with fresh 
preheated (at 37°C) dissolution medium. The 
amount of drug released will be determined 
spectrophotometrically at λmax = 320 utilizing 
UV/VIS Spectrophotometer, Evolution 60S, 
(Thermo Scientific, USA). The standard 
calibration curve showed good linearity with R2 = 
0.9983 and regression equation, y = 0.0076 + 
0.0635. 
 
Kinetic analysis of release profiles 
 
To determine the release kinetic model and 
mechanisms, the dissolution data for each 
formula were analyzed using three kinetic 
models including the zero-order (Eq 1), Hixon-
Crowell (Eq 2), and Higuchi (Eq 3) equations. 
The equation with the best fit was considered 
indicative for the kinetic model that best 
describes the release of the drug. In order to 
further investigate the release mechanism, the 
data were analyzed using Korsmeyer-Peppas 
equation (Eq 4) and the value of the release 
exponent was used to confirm the kinetic model 
of release. 
 
Mt /M∞ = K0 t ……………………..(1) 
 
(1 - Mt /M∞)1/3 = 1001/3 – Kxt……..(2) 
 
Mt /M∞ = kh t1/2 ……………...........(3) 
 
Mt /M∞ = Kp tn ……………………..(4) 
 
where Mt /M∞ is the fraction of drug released 
from a tablet after time t. K0, Kx, kh, and Kp are 
the rate constant of zero-order, Hixon-Crowell, 
Higuchi, and Korsmeyer-Peppas models and n is 





Difference between the drug cumulative amounts 
released from each tested tablet at each time 
point values (mean ± SD) was carried out using 
one way analysis of variance (ANOVA), followed 
by an appropriate post hoc test in the case of 
presence of significant difference. P < 0.05 will 
be taken as a criterion for a statistically 




The physical characteristics of each of the 
prepared batch are summarized in Table 2. It is 
clear that all of the batches showed very good 
attributes with high hardness in the range of 100 
– 110 N and very low friability values below 0.5 
%. They all showed elegant appearance as 
shown in Figure 1 with clearly definite drug core 
layer. The core layer thickness varied from 1 to 
2.17 mm. The thickness to diameter ratios were 
in the range from 0.09 to 0.32. 
 
Table 2: Some physical characteristics of the 
formulations 
 
Parameter Batch 1 Batch 2 Batch 3 Batch 4 
Hardness (N) 110 107 105 101 
Friability (%) 0.3 0.2 0.5 0.5 
Thickness (mm) 1.0 1.02 1.9 2.17 




Figure 1: Photograph of a representative tablet from 
each of the prepared batches 
 
The employed analytical method showed very 
high sensitivity for the determination of low 
concentrations of Ind. The standard calibration 
curve indicated high correlation in the range of 
concentrations from 10 to 50 µg/ml (Table 3). 
 
The release profile of Ind from the four batches is 
presented in Figure 2. It is clear that all the four 
formulations exhibited a slow release profile with 
varying rate. B3 showed the fastest release 
among all the formulations while B2 was the 
slowest. The cumulative % Ind released after 1 h 
were 19.9 ± 1.2, 12.17 ± 1.5, 36.18 ± 3.2 and 
17.51 ± 1.4 % for B1, B2, B3, and B4, 
respectively. It is clear that only B3 showed 
relatively high burst release. The time needed for 
50 % Ind release was estimated to be 3.34, 3.72, 
1.47, and 2.06 h for B1, B2, B3, and B4, 
respectively. After 4h, the cumulative % Ind 
released reached 79.8 ± 5.4 % for B4, 87.76 ± 
6.90 % for B3, 55.36 ± 14.90 % for B2 and 62.81 
± 19.2 % for B1. 
 
Figure 3 shows a plot of the ratio of thickness to 
diameter against the cumulative % Ind released  
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Figure 2: Cumulative percent released Indomethacin from four different geometrically modified-release tablets 
 
 
Figure 3: Correlation between thickness/diameter ration with cumulative percent Ind released after 4 hours 
 





Zero order Higuchi Hixon-Crowell Korsmeyer-Peppas 
exponent (n) 
B1 0.9634 0.9301 0.9614 0.8153 
B2 0.9513 0.9815 0.9898 0.8612 
B3 0.9868 0.9383 0.9601 0.9003 
B4 0.9281 0.9127 0.896 0.7281 
 
after 3, 4 and 6h. It is clear that the ratio of 
thickness to diameter is inversely proportional to 
the rate of drug release and as the ratio gets 
higher values the Ind release rate gets slower at 
the three time periods. The values of the squared 
regression were 0.88, 0.93, and 0.95 after 3, 4 
and 6 h, respectively. This depicts the existence 
of high level of correlation between the ratio of 
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thickness to diameter of the tablets and the % of 
Ind released. The correlation is increasing with 
the increase in the release time. 
 
Analysis of the drug release kinetics revealed 
higher r values with both zero order and Hixon-
Crowell models for all formulations except B4 
which showed higher values with Zero order and 
Higuchi models. However the values of the 
Korsmeyer-Peppas model exponent, n, were all 
higher than 0.5 and below 1. This indicates a 




It was proposed by Abdul and Poddar [14] and 
Qiu et al [15] that in order to achieve a linear 
drug release from a three-layered controlled 
release tablets, hydrophobic core layer and two 
hydrophilic barrier layers are necessary design. 
On the other hand, the triple-layered Geomatrix® 
tablets design showed a hydrophilic matrix core 
layer and two semipermeable hydrophobic 
barrier layers. However in our work, the core was 
a mixture of hydrophobic and hydrophilic 
polymers while the barrier layers were 
completely hydrophobic in nature.  
 
Kim [16] described a three-layered donut-shape 
tablet composed of a core layer matrix made 
mainly of the enteric polymer hydroxypropyl 
methylcellulose acetate succinate and two barrier 
layers on either sides made of ethylcellulose. He 
showed that the system is capable of providing a 
constant zero-order release for a variety of drugs 
at 10% drug loading in the core layer. The pH 
dependency of the core layer is considered a 
limitation in this design compared with our 
proposed core layer composed of ethylcellulose 
and PVP. 
 
Choi et al [17] introduced a novel design for a 
three-layered controlled release tablet composed 
of a hydrophilic middle layer and two barrier 
layers containing swellable hydrophilic polymers. 
The design allowed wrapping of the middle layer 
by the swelling of the barrier layers and drug 
release was through the barrier layers only. Key 
factors for the success of this system is the 
dimensions of the three layers and the nature 
and properties of the barrier layer polymers. 
 
The high correlation between a dimensional 
factor in the design of the system and the release 
rate reflects the geometrical nature of the 
produced controlled release systems and the 
possibility of extrapolating this relation to prepare 
a system with specified intended release rate. 
Such correlation can be tailored toward 
designing many controlled release tablets with a 
variety of release rates.  
 
The employed technique in producing a three-
layered tablet in a single step compression is 
considered advantageous over the multiple 
compression tableting technique due to the high 
simplicity, the ease of application in 





The new one-compression phase introduced in 
this study has successfully produced three-
layered controlled release tablets in a single-step 
with good mechanical attributes. The use of non-
swelling drug release layer is useful for 
maintaining almost constant surface area all over 
the drug release period. This can be utilized in 
developing useful mathematical correlations and 
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